These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2569994)

  • 21. [Introduction of a new antihistamine generation].
    Hautarzt; 1997 Aug; 48(8 Suppl):2. PubMed ID: 9378644
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.
    Gibson JR; Harvey SG; Barth JH; Moss MY; Burke CA
    Dermatologica; 1984; 169(4):179-83. PubMed ID: 6149965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.
    Berlin J; King AC; Tutsch K; Findlay JW; Kohler P; Collier M; Clendeninn NJ; Wilding G
    Invest New Drugs; 1994; 12(2):137-41. PubMed ID: 7860231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acrivastine--a new antihistaminic].
    Bindslev-Jensen C; Thestrup-Pedersen K
    Ugeskr Laeger; 1990 Jul; 152(28):2062-3. PubMed ID: 1973315
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rhinitis therapy. Experiences with triprolidine hydrochloride/pseudoephedrin hydrochloride, a decongestive and antiallergic therapeutic agent].
    Bucke B; Distler HJ; Schoyerer R; Willner W
    Fortschr Med; 1983 Mar; 101(11):494-6. PubMed ID: 6133825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fexofenadine--progress in antihistamine therapy].
    Merk HF
    Hautarzt; 1997 Aug; 48(8 Suppl):8. PubMed ID: 9378648
    [No Abstract]   [Full Text] [Related]  

  • 28. An evaluation of the antihistamine activity of acrivastine and its onset in human skin.
    Manna VK; Marks P; Gibson JR
    J Int Med Res; 1992 Apr; 20(2):106-11. PubMed ID: 1355745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of antihistamine acrivastine in plasma by solid-phase extraction and high-performance liquid chromatography.
    Collins BR; Gu X
    J Pharm Biomed Anal; 2007 Jan; 43(1):293-7. PubMed ID: 16930917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography.
    Gu X; Li H; Macnair KR; Simons FE; Simons KJ
    J Pharm Biomed Anal; 2005 Apr; 37(4):663-7. PubMed ID: 15797786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects.
    Cohen AF; Hamilton M; Philipson R; Peck AW
    Clin Pharmacol Ther; 1985 Oct; 38(4):381-6. PubMed ID: 3840066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ambulatory testing of a new antihistaminic. Experience with Tavegil].
    Weitgasser H
    Munch Med Wochenschr; 1967 May; 109(20):1134-6. PubMed ID: 4384702
    [No Abstract]   [Full Text] [Related]  

  • 33. Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study.
    Petersen LJ; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Allergy; 1994 Jan; 49(1):27-30. PubMed ID: 7911009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers.
    Rolan PE; Phillips S; Adams J; Posner J
    Eur J Clin Pharmacol; 1990; 39(3):311-3. PubMed ID: 1979541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of the antihistaminic activity of a new antihistaminic product with selective and non hypnotic action (HS 592)].
    De Caro L; Rizzo SC
    Folia Allergol (Roma); 1969; 16(3):234-48. PubMed ID: 4397213
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative gas chromatographic-mass spectrometric analysis of acrivastine and a metabolite in human plasma.
    Chang SY; Nelson FR; Findlay JW; Taylor LC
    J Chromatogr; 1989 Dec; 497():288-95. PubMed ID: 2576270
    [No Abstract]   [Full Text] [Related]  

  • 37. Acrivastine/pseudoephedrine for allergic rhinitis.
    Nurse Pract; 1995 Mar; 20(3):16-7. PubMed ID: 7761037
    [No Abstract]   [Full Text] [Related]  

  • 38. [Further development of terfenadine].
    Paul E
    Hautarzt; 1997 Aug; 48(8 Suppl):7. PubMed ID: 9378647
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of acrivastine and terfenadine on skin reactivity to histamine.
    Leynadier F; Murrieta M; Dry J; Colin JN; Gillotin C; Steru D
    Ann Allergy; 1994 Jun; 72(6):520-4. PubMed ID: 7911286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical test on the effect of the new antihistaminic preparation HS-592 (Tavegyl, Sandoz)].
    Zukowski W; Smolik R; Kmietowicz-Zukowska A; Gruszka S; Kwiatkowski S
    Przegl Lek; 1969 Apr; 25(4):379-82. PubMed ID: 4389304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.